Cybrdi Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2009
2010
2011
2012
2013
Net Income before Extraordinaries
596.90
750.70
599.80
529.80
548.40
Depreciation, Depletion & Amortization
170.50
172.60
268.20
248.70
148.00
Other Funds
164.20
-
171.30
224.10
-
Funds from Operations
399.00
301.20
334.30
444.60
465.80
Changes in Working Capital
601.30
382.30
725.30
394.90
670.80
Net Operating Cash Flow
202.30
81.10
391.00
49.80
1,136.60
Capital Expenditures
271.80
655.50
672.50
76.60
66.30
Sale of Fixed Assets & Businesses
10.00
68.80
136.50
79.20
-
Net Investing Cash Flow
401.30
565.40
536.00
2.60
72.10
Issuance/Reduction of Debt, Net
284.90
186.00
136.20
-
436.10
Net Financing Cash Flow
120.60
186.00
307.50
224.10
436.10
Net Change in Cash
480.10
276.40
196.00
175.20
752.30
Free Cash Flow
69.50
574.30
281.50
126.40
1,203.00
Deferred Taxes & Investment Tax Credit
35.10
-
-
-
-
Other Sources
740.00
21.20
-
-
-
Exchange Rate Effect
2.80
21.90
33.50
1.70
20.30
Other Uses
77.00
-
-
-
5.80

About Cybrdi

View Profile
Address
No. 29, Chang'an South Road
Xi'an Shaanxi 710061
China
Employees -
Website http://www.cybrdi.com
Updated 07/08/2019
Cybrdi, Inc. is a holding company, which engages in the business of the distribution of magnetic media products, primarily blank audio and video cassettes. It manufactures both human and animal tissue micro-array for a wide variety of scientific uses, including drug discovery and development. The company is operating through three operating segments and two reportable segments, including Chaoying Biotech and SD Chaoying.